RLAIX
Price
$23.91
Change
+$0.34 (+1.44%)
Updated
Jul 6 closing price
Net Assets
452.55M
VPACX
Price
$21.99
Change
+$0.80 (+3.78%)
Updated
Jul 6 closing price
Net Assets
13.83B
Interact to see
Advertisement

RLAIX vs VPACX

RLAIX vs VPACX Comparison Chart in %
View a ticker or compare two or three
VS
RLAIX vs. VPACX commentary
Jul 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLAIX is a Buy and VPACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VPACX has more cash in the bank: 13.8B vs. RLAIX (453M). RLAIX pays higher dividends than VPACX: RLAIX (3.50) vs VPACX (2.55). RLAIX was incepted earlier than VPACX: RLAIX (9 years) vs VPACX (36 years). RLAIX (1.21) is less costly to investors than VPACX (0.23). RLAIX is a more actively managed with annual turnover of: 34.20 vs. VPACX (7.00). VPACX has a lower initial minimum investment than RLAIX: VPACX (0) vs RLAIX (500000). VPACX annual gain was more profitable for investors over the last year : 35.73 vs. RLAIX (16.42). VPACX return over 5 years is better than : 39.08 vs. RLAIX (21.15).
RLAIXVPACXRLAIX / VPACX
Total Expense Ratio1.080.23470%
Annual Report Gross Expense Ratio1.210.23526%
Fund Existence9 years36 years-
Gain YTD7.57622.62733%
Front LoadN/AN/A-
Min. Initial Investment5000000-
Min. Initial Investment IRAN/AN/A-
Net Assets453M13.8B3%
Annual Yield % from dividends3.502.55137%
Returns for 1 year16.4235.7346%
Returns for 3 years23.8864.2637%
Returns for 5 years21.1539.0854%
Returns for 10 yearsN/A110.55-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRME3.87N/A
N/A
Prime Medicine
ENGN1.78N/A
N/A
enGene Therapeutics Inc
EHGO2.08N/A
N/A
Eshallgo Inc.
RL396.32-1.90
-0.48%
Ralph Lauren Corp
SKE28.16-0.54
-1.88%
Skeena Resources Limited